TCRT Earnings
Latest RevenueN/A
Latest Net Income-952000
| Period | EPS | Revenue | Net Income | Rev YoY | EPS YoY |
|---|
| Q2 2026 | -$0.41 | 0 | -952000 | — | +34.9% |
| Q1 2026 | -$0.59 | 0 | -1006000 | -100.0% | +11.9% |
| Q4 2025 | -$0.43 | 3.0K | -893000 | -25.0% | +6.5% |
| Q3 2025 | -$0.55 | 0 | -1159000 | — | +21.4% |
| Q2 2025 | -$0.63 | 0 | -1051000 | -100.0% | +11.3% |
| Q1 2025 | -$0.67 | 2.0K | -1073000 | +100.0% | +36.2% |
| Q4 2024 | -$0.46 | 4.0K | -742000 | +300.0% | +73.7% |
| Q3 2024 | -$0.70 | 0 | -1127000 | — | +86.8% |
| Q2 2024 | -$0.71 | 4.0K | -1129000 | — | — |
| Q1 2024 | -$1.05 | 1.0K | -1682000 | — | — |
| Q4 2023 | -$1.75 | 1.0K | -7843000 | — | — |
| Q3 2023 | -$5.30 | 0 | -8476000 | — | — |
Alaunos Therapeutics (TCRT) — Earnings